Related Experiment Video
Updated: Apr 1, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
11.2K
Thrombocytopenia Is Associated With Multi-organ System Failure in Patients With Acute Liver Failure
R Todd Stravitz1, Caitlyn Ellerbe2, Valerie Durkalski2
1Section of Hepatology and Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, Virginia.
Summary
In acute liver failure (ALF), low platelet counts (thrombocytopenia) indicate severe systemic inflammation and organ failure, predicting a poor outcome. This highlights platelets as a key indicator of ALF severity and prognosis.
Area of Science:
- Hepatology
- Hematology
- Critical Care Medicine
Background:
- Acute liver failure (ALF) is a complex syndrome involving intense systemic inflammatory response (SIRS) and multi-organ system failure (MOSF).
- Platelet-derived microparticles correlate with SIRS and MOSF severity, indicating poor prognosis in ALF.
- The relationship between thrombocytopenia and ALF severity, MOSF, and patient outcomes requires further investigation.
Purpose of the Study:
- To investigate the correlation between thrombocytopenia and the severity of systemic inflammatory response (SIRS), multi-organ system failure (MOSF), and outcomes in patients with acute liver failure (ALF).
Main Methods:
- A retrospective analysis of 1598 patients from the ALF Study Group Registry (1998-2012).
- Collected and analyzed post-admission platelet counts, correlating them with clinical features, laboratory values, and patient outcomes (survival, liver transplantation, death).
Main Results:
- Patients with SIRS exhibited decreased platelet counts 2-7 days post-admission compared to those without SIRS (P ≤ .001).
- Lower platelet counts were significantly associated with abnormal creatinine, phosphate, lactate, or bicarbonate levels (all P ≤ .001).
- Platelet decrease correlated with hepatic encephalopathy grade and need for vasopressors or renal replacement therapy, and was lower in patients with poor outcomes (death or transplant).
Conclusions:
- Thrombocytopenia in ALF is a significant indicator of developing MOSF and predicts poor patient outcomes.
- SIRS-induced platelet activation and microparticle formation may lead to platelet clearance and subsequent thrombocytopenia in ALF.
- Platelet count serves as a valuable prognostic marker in acute liver failure management.
More Related Videos
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
335
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
01:29Acute Kidney Injury II: Pathophysiology
1.9K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.9K
01:29Acute Kidney Injury III: Clinical Manifestations
1.4K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
01:22Acute Kidney Injury I: Introduction
1.2K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.2K
01:21Hepatic Portal System
7.8K
The hepatic portal system, a critical part of our circulatory framework, transports nutrient-laden, deoxygenated blood from the gastrointestinal tract and spleen to the liver. This ingenious system plays an indispensable role in maintaining our body's metabolic equilibrium.
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
7.8K